Considerations for comparative tobacco product assessments based on smoke constituent yields

Regulatory Toxicology and Pharmacology

Volumn 73, Issue 1, 2015, Pages 105-113

  Belushkin, M ^a   Jaccard, G ^a   Kondylis, A ^b  

^a PHILIP MORRIS PRODUCTS S A   (Switzerland)

^b Philip Morris Products SA   (Switzerland)

Author keywords

Cigarette smoke constituent; Quantitative comparisons; Tobacco regulations

Indexed keywords

1 NAPHTHYLAMINE; 1,3 BUTADIENE; 2 BUTANONE; 2 NAPHTHYLAMINE; 3 AMINOBIPHENYL; 4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANONE; 4 BIPHENYLAMINE; ACETONE; ACROLEIN; AMMONIA; BENZO[A]PYRENE; BIPHENYL DERIVATIVE; BUTYRALDEHYDE; CADMIUM; CATECHOL; CIGARETTE SMOKE; CRESOL; CROTONALDEHYDE; FORMALDEHYDE; HYDROQUINONE; NICOTINE; NITRIC OXIDE; NITROGEN OXIDE; NITROSONORNICOTINE; PHENOL; PROPIONALDEHYDE; PYRIDINE; QUINOLONE; STYRENE; UNCLASSIFIED DRUG; UNINDEXED DRUG; SMOKE;

ARTICLE; CHEMICAL ANALYSIS; CHEMICAL COMPOSITION; COMPARATIVE STUDY; CONTROLLED STUDY; HEALTH CARE POLICY; POSTMARKETING SURVEILLANCE; PRIORITY JOURNAL; SMOKING REGULATION; STUDENT T TEST; TOBACCO; ADVERSE EFFECTS; ANALYSIS; ANATOMY AND HISTOLOGY; HUMAN; SMOKE; SMOKING;

NICOTIANA TABACUM;

HUMANS; SMOKE; SMOKING; TOBACCO; TOBACCO PRODUCTS;

EID: 84936854498     PISSN: 02732300     EISSN: 10960295     Source Type: Journal    
DOI: 10.1016/j.yrtph.2015.06.017     Document Type: Article

References (51)

1. Baker R.R., et al. The effect of tobacco ingredients on smoke chemistry. Part 1: flavourings and additives. Food Chem. Toxicol. 2004, 42s:S3-S37.
2. Berger R.L., Hsu J.C. Bioequivalence trials, intersection-union tests and equivalence confidence sets. Stat. Sci. 1996, 11:283-319.
3. Brazil National Health Surveillance Agency ANVISA Resolution RDC No. 90 Rules on the Registration of Data from Tobacco-derived Smoking Products 2007.
4. Burns D.M., et al. Mandated lowering of toxicants in cigarette smoke: a description of the World Health Organization TobReg proposal. Tob. Control 2008, 17:132-141.
5. Counts M.E., et al. Mainstream smoke constituent yields and predicting relationships from a worldwide market sample of cigarette brands: ISO smoking conditions. Regul. Toxicol. Pharmacol. 2004, 39:111-134.
6. Counts M.E., et al. Development of a commercial cigarette "market map" comparison methodology for evaluating new or non-conventional cigarettes. Regul. Toxicol. Pharmacol. 2006, 46:225-242.
7. Dangi Y.S., et al. Highly variable drugs: bioequivalence requirements and regulatory perspectives. J.Curr. Pharm. Res. 2010, 3:24-28.
8. Dolka C., et al. Menthol addition to cigarettes using breakable capsules in the filter. Impact on the mainstream smoke yields of the Health Canada list constituents. Chem. Res. Toxicol. 2013, 26:1430-1443.
9. Eldridge A., et al. Variation in tobacco and mainstream smoke toxicant yields from selected commercial cigarette products. Regul. Toxicol. Pharmacol. 2015, 71:409-427.
10. European Medicines Agency Committee for Medicinal Products for Human Use Guideline on the Investigation of Bioequivalence 2010, last accessed 29/05/2015. http://www.ema.europa.eu/ema/pages/includes/document/open_document.jsp?webContentId=WC500070039.
11. Hanna S.N., et al. Contribution of manufacturing to variability in cigarette constituent levels. CORESTA Congress, Québec, 2014 2014.
12. Haussmann H.J. Use of hazard indices for a theoretical evaluation of cigarette smoke composition. Chem. Res. Toxicol. 2012, 25:794-810.
13. Health Canada Tobacco reporting regulations (SOR/DORS/2000-273). Can. Gaz. Part Ii. 2000, 134:1761-1792.
14. Health Canada Tobacco Reporting Regulations 2012, last accessed 17/02/2015). Health Canada. http://www.hc-sc.gc.ca/hc-ps/tobac-tabac/legislation/reg/indust/index-eng.php.
15. Hoffmann D., Wynder E.L. Chemical Constituents and Bioactivity of Tobacco Smoke 1986, 145-165. IARC scientific publications.
16. Horwitz W., Albert R. The Horwitz ratio (HorRat): a useful index of method performance with respect to precision. J.AOAC Int. 2006, 89:1095-1109.
17. International Organization for Standardization Cigarettes - Determination of Water in Smoke Condensates - Part 1: Gas-chromatographic Method 1999, Geneva, Switzerland, ISO 10362-1.
18. International Organization for Standardization ISO 3308-Routine Analytical Cigarette-smoking Machine - Definitions and Standard Conditions 2000, Geneva, Switzerland.
19. International Organization for Standardization Determination of Total and Nicotine-free Dry Particulate Matter Using Routine Analytical Smoking Machine 2000, Geneva, Switzerland, ISO 4387.
20. International Organization for Standardization General Requirements for the Competence of Testing and Calibration Laboratories 2005, Geneva, Switzerland, ISO/IEC 17025.
21. International Organization for Standardization Cigarettes - Determination of Carbon Monoxide in the Vapour Phase of Cigarette Smoke - NDIR Method 2007, Geneva, Switzerland, ISO 8454.
22. International Organization for Standardization Cigarettes - Determination of Benzo[a]pyrene in Cigarette Mainstream Smoke - Method Using Gas Chromatography/mass Spectrometry 2008, Geneva, Switzerland, ISO 22634.
23. International Organization for Standardization Cigarettes - Determination of Menthol in Smoke Condensates - Gas-chromatographic Method 2012, Geneva, Switzerland, ISO 13110.
24. International Organization for Standardization Cigarettes - Sampling 2013, Geneva, Switzerland, ISO 8243.
25. International Organization for Standardization Cigarettes - Determination of Nicotine in Smoke Condensates - Gas-chromatographic Method 2013, Geneva, Switzerland, ISO 10315.
26. International Organization for Standardization Cigarettes - Determination of Water in Smoke Condensates - Part 2: Karl Fischer Method 2013, Geneva, Switzerland, ISO 10362-2.
27. Intorp M., Purkis S. Determination of selected volatiles in cigarette mainstream smoke. The CORESTA 2008 joint experiment. Beitrage zur Tabakforschung International Contributions Tob. Res. 2010, 24:174-186.
28. Intorp M., et al. Determination of carbonyl compounds in cigarette mainstream smoke. The CORESTA 2010 collaborative study and recommended method. Beitrage zur Tabakforschung International/Contributions Tob. Res. 2012, 25:361-374.
29. Intorp M., et al. Determination of tobacco specific nitrosamines in cigarette mainstream smoke: the CORESTA 2011 collaborative study. Beitrage zur Tabakforschung International Contributions Tob. Res. 2012, 25:507-519.
30. Intorp M., et al. Determination of selected volatiles in cigarette mainstream smoke. The CORESTA 2009 collaborative study and recommended method. Beitrage zur Tabakforschung International/Contributions Tob. Res. 2011, 24:243-251.
31. Limentani G.B., et al. Beyond the t-test: statistical equivalence testing. Anal. Chem. 2005, 77. 221 A-226 A.
32. Miller R.G. Simultaneous Statistical Inference 1981, Springer. second ed.
33. Minagawa K. The long-term variability of selected smoke constituents of commercial brands in the Japanese market. CORESTA Congress 2012, Sapporo, Japan 2012.
34. Oldham M.J., et al. Insights from analysis for harmful and potentially harmful constituents (HPHCs) in tobacco products. Regul. Toxicol. Pharmacol. 2014, 70:138-148.
35. Oldham M.J., et al. Discriminatory power of standard toxicity assays used to evaluate ingredients added to cigarettes. Regul. Toxicol. Pharmacol. 2012, 62:49-61.
36. Piadé J.J., et al. Formation of mainstream cigarette smoke constituents prioritized by the World Health Organization - yield patterns observed in market surveys, clustering and inverse correlations. Food Chem. Toxicol. 2013, 55:329-347.
37. Purkis S.W., et al. Some consequences of using cigarette machine smoking regimes with different intensities on smoke yields and their variability. Regul. Toxicol. Pharmacol. 2011, 59:293-309.
38. Purkis S.W., et al. Areview of the UK methodology used for monitoring cigarette smoke yields, aspects of analytical data variability and their impact on current and future regulatory compliance. Regul. Toxicol. Pharmacol. 2010, 56:365-373.
39. Purkis S.W., et al. Areview of current smoke constituent measurement activities and aspects of yield variability. Regul. Toxicol. Pharmacol. 2012, 62:202-213.
40. Purkis S.W., et al. Limitations in the characterisation of cigarette products using different machine smoking regimes. Regul. Toxicol. Pharmacol. 2010, 58:501-515.
41. Rodgman A., Perfetti T.A. The Chemical Components of Tobacco and Tobacco Smoke 2013, CRC press.
42. Roemer E., Carchman R.A. Limitations of cigarette machine smoking regimens. Toxicol. Lett. 2011, 203:20-27.
43. Taiwan Ministry of Health and Welfare - Health Promotion Administration Regulations Governing Reporting of Tobacco Product Information 2012, last accessed 27/11/2014. http://www.hpa.gov.tw/BHPNet/English/ClassShow.aspx?No=200907130001.
44. Talhout R., et al. Hazardous compounds in tobacco smoke. Int. J. Environ. Res. Public Health 2011, 8:613-628.
45. Teillet B., et al. Comparison of smoke yield data collected from different laboratories. Beitrage zur Tabakforschung International/Contributions Tob. Res. 2013, 25:662-670.
46. U.S.Food and Drug Administration Guidance for Industry: Statistical Approaches to Establishing Bioequivalence 2001, last accessed 15/08/2014]. http://www.fda.gov/downloads/Drugs/Guidances/ucm070244.pdf.
47. U.S.Food and Drug Administration Section 904 "Submission of Health Information to the Secretary" of the Federal Food, Drug, and Cosmetic Act 2010.
48. U.S.Food and Drug Administration Guidance for Industry: Applications for Premarket Review of New Tobacco Products 2011, last accessed 06/01/2015. http://www.fda.gov/downloads/TobaccoProducts/GuidanceComplianceRegulatoryInformation/UCM273425.pdf.
49. U.S.Food and Drug Administration Reporting Harmful and Potentially Harmful Constituents in Tobacco Products and Tobacco Smoke under Section 904(a)(3) of the Federal Food, Drug, and Cosmetic Act 2012, last accessed 27/11/2014). Guidance for Industry. http://www.fda.gov/downloads/TobaccoProducts/GuidanceComplianceRegulatoryInformation/UCM297828.pdf.
50. Verron T., et al. ST29 product comparison: the risk associated with multiple testing. CORESTA Congress, Québec, 2014 2014.
51. World Health Organization The Scientific Basis of Tobacco Product Regulation 2008, WHO Technical Report Series. 951.